Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Samuels

Showing results (241-250 of 253) with videos related to

Pageof 26
Sort By:
The Laryngoscope|June 9, 2022
Oral and Inhaled Fosamprenavir Reverses Pepsin-Induced Damage in a Laryngopharyngeal Reflux Mouse ModelNikki Johnston, Tina L Samuels, Christopher J Goetz, et al.
Cancer Chemotherapy and Pharmacology|August 10, 2006
Androgen and c-Kit receptors in desmoplastic small round cell tumors resistant to chemotherapy: novel targets for therapyRobert L Fine, Samir S Shah, Thomas A Moulton, et al.
Nature Biotechnology|November 3, 2009
Microdroplet-based PCR enrichment for large-scale targeted sequencingRyan Tewhey, Jason B Warner, Masakazu Nakano, et al.
Molecular Therapy. Nucleic Acids|July 25, 2013
BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular VesiclesWalter W Chen, Leonora Balaj, Linda M Liau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2009
Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedulesGeorge D Demetri, Sant P Chawla, Margaret von Mehren, et al.
Plos Pathogens|June 3, 2016
Human Galectin-9 Is a Potent Mediator of HIV Transcription and ReactivationMohamed Abdel-Mohsen, Leonard Chavez, Ravi Tandon, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 27, 2011
ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursorsPaul L Bollyky, Rebecca P Wu, Ben A Falk, et al.
Diabetes|June 23, 2012
Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell functionS Alice Long, Mary Rieck, Srinath Sanda, et al.
Cancer|December 29, 2015
SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcomaScott M Schuetze, J Kyle Wathen, David R Lucas, et al.
Cancer|October 4, 2016
Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumorScott M Schuetze, Vanessa Bolejack, Edwin Choy, et al.
Pageof 26

Showing results (241-250 of 253) with videos related to

Sort By:
Pageof 26
The Laryngoscope|June 9, 2022
Oral and Inhaled Fosamprenavir Reverses Pepsin-Induced Damage in a Laryngopharyngeal Reflux Mouse ModelNikki Johnston, Tina L Samuels, Christopher J Goetz, et al.
Cancer Chemotherapy and Pharmacology|August 10, 2006
Androgen and c-Kit receptors in desmoplastic small round cell tumors resistant to chemotherapy: novel targets for therapyRobert L Fine, Samir S Shah, Thomas A Moulton, et al.
Nature Biotechnology|November 3, 2009
Microdroplet-based PCR enrichment for large-scale targeted sequencingRyan Tewhey, Jason B Warner, Masakazu Nakano, et al.
Molecular Therapy. Nucleic Acids|July 25, 2013
BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular VesiclesWalter W Chen, Leonora Balaj, Linda M Liau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2009
Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedulesGeorge D Demetri, Sant P Chawla, Margaret von Mehren, et al.
Plos Pathogens|June 3, 2016
Human Galectin-9 Is a Potent Mediator of HIV Transcription and ReactivationMohamed Abdel-Mohsen, Leonard Chavez, Ravi Tandon, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 27, 2011
ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursorsPaul L Bollyky, Rebecca P Wu, Ben A Falk, et al.
Diabetes|June 23, 2012
Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell functionS Alice Long, Mary Rieck, Srinath Sanda, et al.
Cancer|December 29, 2015
SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcomaScott M Schuetze, J Kyle Wathen, David R Lucas, et al.
Cancer|October 4, 2016
Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumorScott M Schuetze, Vanessa Bolejack, Edwin Choy, et al.
Pageof 26